头颈癌放射治疗自动化虚拟整合计划器的开发与临床实施
本研究基于668例既往头颈癌放疗计划开发了自动化虚拟整合知识库计划器(AVI),并在52例近期头颈癌病例中回顾性验证。初始86%的计划可接受治疗,AVI计划器显著降低了喉平均剂量(中位数18.5 vs 19.7 Gy,P<.01)并大幅缩短交互优化时间(平均2 vs 85分钟,P<.01)。
要点
- AVI计划器基于668例既往头颈癌放疗计划库开发,经前瞻性危害分析后临床发布。
- 52例回顾性验证中初始86%计划可接受治疗,10%需小修,4%需大修或拒绝。
- AVI计划器显著降低喉平均剂量(中位数18.5 vs 19.7 Gy,P<.01)并缩短优化时间(平均2 vs 85分钟,P<.01)。
核心结论
- AVI计划器可可靠地为口腔、唾液腺、口咽、喉及下咽癌生成临床可接受的放疗计划。
- 医师驱动的迭代学习过程使头颈癌放疗计划质量获得有利演进,并显著节省时间、提高一致性。
研究设计与样本
- 基于668例既往治疗的头颈癌放疗计划库开发院内可写脚本,临床发布前进行前瞻性危害分析并实施缓解策略。
- 在52例近期头颈癌病例中回顾性验证AVI计划器软件。
- 初始部署期间由医师小组评估计划局限性,并通过软件改进落实反馈,随后生成并评估第二组最终计划。
主要发现
- 初始86%的计划可接受治疗,10%建议小修,4%建议大修或拒绝。
- 计划质量在头颈癌各亚部位间存在差异,口咽和口腔计划初始质量高。
- 需修订的计划包括鼻腔鼻窦、鼻咽、P-16阴性鳞状细胞癌原发灶不明或皮肤原发部位。
- AVI计划器较临床计划显著降低喉平均剂量(中位数18.5 vs 19.7 Gy;P<.01)。
- AVI计划器较手动优化显著缩短交互优化时间(平均2 vs 85分钟;P<.01)。
关键数值与推荐
- 采用Kolmogorov-Smirnov检验、广义评价指标和加权经验评分比较最终AVI计划器与相应临床治疗及历史可接受计划的正常组织保护。
- 采用t检验比较AVI计划器与手动优化的交互时间、复杂度和机器跳数。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Head and neck (HN) radiation (RT) treatment planning is complex and resource intensive. Deviations and inconsistent plan quality significantly affect clinical outcomes. We sought to develop a novel automated virtual integrative (AVI) knowledge-based planning application to reduce planning time, increase consistency, and improve baseline quality. METHODS AND MATERIALS: An in-house write-enabled script was developed from a library of 668 previously treated HN RT plans. Prospective hazard analysis was performed, and mitigation strategies were implemented before clinical release. The AVI-planner software was retrospectively validated in a cohort of 52 recent HN cases. A physician panel evaluated planning limitations during initial deployment, and feedback was enacted via software refinements. A final second set of plans was generated and evaluated. Kolmogorov-Smirnov test in addition to generalized evaluation metric and weighted experience score were used to compare normal tissue sparing between final AVI planner versus respective clinically treated and historically accepted plans. A t test was used to compare the interactive time, complexity, and monitor units for AVI planner versus manual optimization. RESULTS: Initially, 86% of plans were acceptable to treat, with 10% minor and 4% major revisions or rejection recommended. Variability was noted in plan quality among HN subsites, with high initial quality for oropharynx and oral cavity plans. Plans needing revisions were comprised of sinonasal, nasopharynx, P-16 negative squamous cell carcinoma unknown primary, or cutaneous primary sites. Normal tissue sparing varied within subsites, but AVI planner significantly lowered mean larynx dose (median, 18.5 vs 19.7 Gy; P < .01) compared with clinical plans. AVI planner significantly reduced interactive optimization time (mean, 2 vs 85 minutes; P < .01). CONCLUSIONS: AVI planner reliably generated clinically acceptable RT plans for oral cavity, salivary, oropharynx, larynx, and hypopharynx cancers. Physician-driven iterative learning processes resulted in favorable evolution in HN RT plan quality with significant time savings and improved consistency using AVI planner.
引用
- Jaworski EM, Mierzwa ML, Vineberg KA, et al. Development and Clinical Implementation of an Automated Virtual Integrative Planner for Radiation Therapy of Head and Neck Cancer. Adv Radiat Oncol. 2022. PMID: 36578278. doi:10.1016/j.adro.2022.101029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。